机译:甲状腺肿瘤中血管生成刺激剂和抑制剂的表达及其与临床病理特征的关系
From the Divisions of Experimental Oncology,Istituto Nazionale Tumori, Milan, Italy;
From the Divisions of Experimental Oncology,Istituto Nazionale Tumori, Milan, Italy;
Medical Statistics and Biometry,Istituto Nazionale Tumori, Milan, Italy;
and Pathology and Cytology,Istituto Nazionale Tumori, Milan, Italy;
and Pathology and Cytology,Istituto Nazionale Tumori, Milan, Italy;
and Pathology and Cytology,Istituto Nazionale Tumori, Milan, Italy;
From the Divisions of Experimental Oncology,Istituto Nazionale Tumori, Milan, Italy;
From the Divisions of Experimental Oncology,Istituto Nazionale Tumori, Milan, Italy;
机译:脑特异性血管生成抑制剂1的表达与人类星形细胞瘤的病理分级,血管生成和肿瘤周围脑水肿呈负相关
机译:miR-375和YAP1表达谱中髓质甲状腺癌及其与临床病理特征和结果的相关性
机译:VHL肿瘤抑制器mRNA和miR-92a在乳头状甲状腺癌中的表达及其与临床和病理参数的相关性
机译:血管生成抑制剂的组合增加了光动力疗法在人膀胱肿瘤异种移植模型中的抗肿瘤功效
机译:Wilms肿瘤的基因表达谱:与肾脏发育的关系及其与临床特征的关系
机译:甲状腺肿瘤中血管生成刺激剂和抑制剂的表达及其与临床病理特征的关系
机译:甲状腺肿瘤中血管生成刺激剂和抑制剂的表达及其与临床病理特征的关系